GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform? ; volume:60 ; number:11 ; day:4 ; month:7 ; year:2023 ; pages:1441-1448 ; date:11.2023
Acta diabetologica ; 60, Heft 11 (4.7.2023), 1441-1448, 11.2023
- Urheber
-
Menghini, Rossella
Casagrande, Viviana
Rizza, Stefano
Federici, Massimo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00592-023-02124-w
- URN
-
urn:nbn:de:101:1-2023121312053897477005
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Menghini, Rossella
- Casagrande, Viviana
- Rizza, Stefano
- Federici, Massimo
- SpringerLink (Online service)
Ähnliche Objekte (12)
The endothelium in cardiovascular disease : pathophysiology, clinical presentation and pharmacotherapy
A Biomicrofluidic Screening Platform for Dysfunctional Endothelium‐Targeted Nanoparticles and Therapeutics
A Biomicrofluidic Screening Platform for Dysfunctional Endothelium‐Targeted Nanoparticles and Therapeutics
Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
GLP (Grünleitplan)
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
Endothelium derived relaxing factors
Endothelium derived contracting factors
Endothelium and Intimal Thickening
The endothelium in cardiovascular disease : pathophysiology, clinical presentation and pharmacotherapy
A Biomicrofluidic Screening Platform for Dysfunctional Endothelium‐Targeted Nanoparticles and Therapeutics
A Biomicrofluidic Screening Platform for Dysfunctional Endothelium‐Targeted Nanoparticles and Therapeutics
Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
GLP (Grünleitplan)
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
Endothelium derived relaxing factors
Endothelium derived contracting factors
Endothelium and Intimal Thickening
The endothelium in cardiovascular disease : pathophysiology, clinical presentation and pharmacotherapy
A Biomicrofluidic Screening Platform for Dysfunctional Endothelium‐Targeted Nanoparticles and Therapeutics
A Biomicrofluidic Screening Platform for Dysfunctional Endothelium‐Targeted Nanoparticles and Therapeutics
Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
GLP (Grünleitplan)
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
Endothelium derived relaxing factors
Endothelium derived contracting factors